X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9271) 9271
Book Chapter (199) 199
Book / eBook (22) 22
Magazine Article (4) 4
Dissertation (1) 1
Newsletter (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8560) 8560
female (6683) 6683
surgery (6580) 6580
male (6303) 6303
medicine & public health (6291) 6291
abdominal surgery (6040) 6040
index medicus (5992) 5992
middle aged (5708) 5708
aged (5187) 5187
adult (3879) 3879
gastroenterology (3178) 3178
cancer (3059) 3059
retrospective studies (2903) 2903
cardiac surgery (2737) 2737
vascular surgery (2732) 2732
thoracic surgery (2669) 2669
treatment outcome (2539) 2539
aged, 80 and over (2434) 2434
general surgery (2432) 2432
analysis (1981) 1981
hepatology (1954) 1954
proctology (1933) 1933
gynecology (1696) 1696
prognosis (1643) 1643
health aspects (1530) 1530
surgical oncology (1516) 1516
laparoscopy (1464) 1464
mortality (1449) 1449
follow-up studies (1440) 1440
gastroenterology & hepatology (1423) 1423
oncology (1357) 1357
neoplasm staging (1325) 1325
risk factors (1324) 1324
carcinoma (1277) 1277
survival rate (1230) 1230
survival (1169) 1169
care and treatment (1050) 1050
resection (1040) 1040
tumors (1004) 1004
laparoscopic surgery (969) 969
colorectal cancer (963) 963
management (959) 959
prospective studies (892) 892
stomach neoplasms - surgery (879) 879
metastasis (872) 872
survival analysis (867) 867
laparoscopy - methods (841) 841
chemotherapy (801) 801
complications (790) 790
colorectal surgery (784) 784
stomach cancer (778) 778
research (769) 769
adolescent (763) 763
liver neoplasms - surgery (750) 750
adenocarcinoma - surgery (727) 727
young adult (711) 711
diagnosis (697) 697
stomach neoplasms - pathology (695) 695
time factors (659) 659
traumatic surgery (643) 643
disease-free survival (628) 628
medical colleges (625) 625
tomography, x-ray computed (625) 625
outcomes (619) 619
postoperative complications (591) 591
morbidity (590) 590
adenocarcinoma (589) 589
gastric cancer (586) 586
postoperative complications - epidemiology (580) 580
lymphatic metastasis (562) 562
oncology, experimental (560) 560
experience (556) 556
length of stay (545) 545
multivariate analysis (540) 540
risk assessment (533) 533
cohort studies (528) 528
rectal neoplasms - surgery (527) 527
colorectal neoplasms - surgery (522) 522
recurrence (520) 520
pancreatic neoplasms - surgery (509) 509
risk (506) 506
patients (503) 503
liver (499) 499
cancer research (488) 488
hepatectomy (481) 481
risk-factors (479) 479
adenocarcinoma - pathology (473) 473
stomach neoplasms - mortality (464) 464
incidence (459) 459
patient outcomes (452) 452
child (445) 445
combined modality therapy (424) 424
gastrectomy (423) 423
abdomen (416) 416
cancer patients (413) 413
hepatectomy - methods (403) 403
pancreaticoduodenectomy (403) 403
colorectal neoplasms - pathology (402) 402
gastrectomy - methods (401) 401
operative time (397) 397
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9236) 9236
Japanese (265) 265
German (93) 93
French (92) 92
Spanish (25) 25
Italian (17) 17
Russian (14) 14
Chinese (7) 7
Danish (3) 3
Hebrew (3) 3
Polish (3) 3
Portuguese (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


World journal of surgery, ISSN 0364-2313, 07/2009, Volume 33, Issue 7, pp. 1502 - 1508
textabstractIntroduction: Complete resection is the most important prognostic factor in surgery for pelvic tumors. In locally advanced and recurrent pelvic... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | CONTINENT URINARY-DIVERSION | MORBIDITY | RESECTION | COLORECTAL-CANCER | INTRAOPERATIVE RADIOTHERAPY | EXPERIENCE | GYNECOLOGICAL MALIGNANCIES | OUTCOMES | ADVANCED RECTAL-CANCER | Endometrial Neoplasms - radiotherapy | Multivariate Analysis | Neoplasm Recurrence, Local - radiotherapy | Prognosis | Endometrial Neoplasms - mortality | Pelvic Exenteration - adverse effects | Humans | Middle Aged | Pelvic Neoplasms - mortality | Male | Uterine Cervical Neoplasms - pathology | Postoperative Complications - mortality | Neoplasm Recurrence, Local - mortality | Hospital Mortality - trends | Neoplasm Recurrence, Local - pathology | Pelvic Neoplasms - radiotherapy | Neoplasm Invasiveness - pathology | Adult | Female | Rectal Neoplasms - pathology | Retrospective Studies | Radiotherapy, Adjuvant | Pelvic Exenteration - methods | Uterine Cervical Neoplasms - mortality | Pelvic Neoplasms - pathology | Pelvic Neoplasms - surgery | Uterine Cervical Neoplasms - radiotherapy | Risk Assessment | Rectal Neoplasms - surgery | Brachytherapy - methods | Kaplan-Meier Estimate | Proportional Hazards Models | Uterine Cervical Neoplasms - surgery | Probability | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Endometrial Neoplasms - surgery | Survival Analysis | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cohort Studies | Chemotherapy | Sarcoma | Health aspects | Cervical cancer | Cancer
Journal Article
Surgery Today, ISSN 0941-1291, 8/2012, Volume 42, Issue 8, pp. 752 - 758
The results and outcomes of surgical resection for esophageal carcinoma have improved remarkably in recent years; however, recurrence still frequently... 
Recurrence | Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | Surgical Oncology | Esophageal cancer | LYMPH-NODE DISSECTION | 2-FIELD | POSITRON-EMISSION-TOMOGRAPHY | EXTENDED RADICAL ESOPHAGECTOMY | THORACIC ESOPHAGUS | DISEASE | SQUAMOUS-CELL CARCINOMA | CURATIVE RESECTION | 3-FIELD LYMPHADENECTOMY | Bone Neoplasms - mortality | Bone Neoplasms - therapy | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Time Factors | Esophageal Neoplasms - surgery | Skin Neoplasms - mortality | Skin Neoplasms - diagnosis | Esophageal Neoplasms - mortality | Retrospective Studies | Liver Neoplasms - secondary | Bone Neoplasms - diagnosis | Skin Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Kaplan-Meier Estimate | Esophagectomy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Liver Neoplasms - diagnosis | Skin Neoplasms - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - diagnosis | Neoplasm Staging | Neck Dissection
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 21, pp. 2883 - 2888
Journal Article
World Journal of Surgery, ISSN 0364-2313, 6/2012, Volume 36, Issue 6, pp. 1419 - 1431
Journal Article
Langenbeck's Archives of Surgery, ISSN 1435-2443, 1/2014, Volume 399, Issue 1, pp. 41 - 53
.... Accumulating evidence underlines the therapeutic potential and the acceptable morbidity and mortality rates of CRS and HIPEC in selected patients. 
Peritoneal surface malignancies | Medicine & Public Health | Cardiac Surgery | HIPEC | Traumatic Surgery | Cytoreductive surgery | Peritoneal carcinomatosis | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | PHASE-III | SURFACE MALIGNANCY | OVARIAN-CANCER | PERIOPERATIVE INTRAPERITONEAL | COMPLETE CYTOREDUCTIVE SURGERY | GASTRIC-CANCER | PSEUDOMYXOMA-PERITONEI | COLORECTAL-CANCER | SYSTEMIC CHEMOTHERAPY | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | Prognosis | Pseudomyxoma Peritonei - surgery | Mesothelioma - pathology | Humans | Ovarian Neoplasms - pathology | Carcinoma - mortality | Mesothelioma - mortality | Stomach Neoplasms - pathology | Ovarian Neoplasms - mortality | Pseudomyxoma Peritonei - drug therapy | Peritoneal Neoplasms - drug therapy | Mesothelioma - surgery | Pseudomyxoma Peritonei - mortality | Hyperthermia, Induced | Pseudomyxoma Peritonei - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Ovarian Neoplasms - drug therapy | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Mesothelioma - drug therapy | Disease-Free Survival | Neoplasm Staging | Stomach Neoplasms - surgery | Intestinal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Chemotherapy, Cancer, Regional Perfusion | Ovarian Neoplasms - surgery | Chemotherapy | Health aspects | Surgery | Analysis | Mortality | Cancer
Journal Article
Journal Article
Annals of Vascular Surgery, ISSN 0890-5096, 01/2019, Volume 54, pp. 72 - 83
Background: Safe resection of intraabdominal and retroperitoneal malignancies with a goal of negative margins may require vascular surgical assistance with... 
SURGERY | MULTICENTER ANALYSIS | MANAGEMENT | PROGNOSTIC-FACTORS | ABDOMINAL AORTIC-ANEURYSM | RESECTION | SARCOMA | SECONDARY | ARTERY ANEURYSM | PERIPHERAL VASCULAR DISEASE | B-CELL-LYMPHOMA | RETROPERITONEAL | Iliac Artery - pathology | Abdominal Neoplasms - diagnostic imaging | Humans | Middle Aged | Male | Lymphoma - mortality | Aorta, Abdominal - diagnostic imaging | Time Factors | Leiomyosarcoma - surgery | Aged, 80 and over | Retroperitoneal Neoplasms - pathology | Tertiary Care Centers | Risk Factors | Incidental Findings | Iliac Artery - surgery | Abdominal Neoplasms - surgery | Blood Vessel Prosthesis Implantation - mortality | Computed Tomography Angiography | Phenotype | Abdominal Neoplasms - mortality | Abdominal Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - surgery | Lymphoma - surgery | Vena Cava, Inferior - surgery | Lymphoma - diagnostic imaging | Ultrasonography, Interventional | Retroperitoneal Neoplasms - mortality | Leiomyosarcoma - diagnostic imaging | Blood Vessel Prosthesis Implantation - adverse effects | Vena Cava, Inferior - pathology | Adult | Female | Lymphoma - pathology | Retrospective Studies | Aorta, Abdominal - pathology | Retroperitoneal Neoplasms - surgery | Neoplasms, Germ Cell and Embryonal - mortality | Leiomyosarcoma - pathology | Neoplasm Invasiveness | Endovascular Procedures - adverse effects | Treatment Outcome | Endovascular Procedures - mortality | Michigan | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Vena Cava, Inferior - diagnostic imaging | Retroperitoneal Neoplasms - diagnostic imaging | Reconstructive Surgical Procedures - mortality | Iliac Artery - diagnostic imaging | Leiomyosarcoma - mortality | Reconstructive Surgical Procedures - adverse effects | Aged | Aorta, Abdominal - surgery | Neoplasms, Germ Cell and Embryonal - pathology
Journal Article
World Journal of Surgery, ISSN 0364-2313, 9/2017, Volume 41, Issue 9, pp. 2312 - 2323
The multiple endocrine neoplasia type 1 syndrome (MEN1) natural history is poorly evaluated, and few single-institution experiences about hereditary... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | DIAGNOSIS | NEUROENDOCRINE TUMORS | MANAGEMENT | PROGNOSTIC-FACTORS | GASTROENTEROPANCREATIC SYSTEM | ENDOSCOPIC ULTRASONOGRAPHY | PREOPERATIVE LOCALIZATION | DEATH | ENDOCRINE NEOPLASIA TYPE-1 | INSULINOMAS | Follow-Up Studies | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Male | Multiple Endocrine Neoplasia Type 1 - mortality | Neuroendocrine Tumors - diagnosis | Gastrinoma - mortality | Pancreaticoduodenectomy | Multiple Endocrine Neoplasia Type 1 - genetics | Young Adult | Time Factors | Adult | Female | Pancreatic Neoplasms - mortality | Intestinal Neoplasms - diagnosis | Intestinal Neoplasms - genetics | Stomach Neoplasms - genetics | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Stomach Neoplasms - diagnosis | Pancreatic Neoplasms - surgery | Multiple Endocrine Neoplasia Type 1 - diagnosis | Pancreatic Neoplasms - genetics | Survival Rate | Gastrinoma - diagnosis | Disease Progression | Neuroendocrine Tumors - genetics | Neuroendocrine Tumors - mortality | Neuroendocrine Tumors - surgery | Gastrinoma - surgery | Gastrinoma - genetics | Mutation | Multiple Endocrine Neoplasia Type 1 - surgery | Stomach Neoplasms - surgery | Stomach Neoplasms - mortality | Medicine, Experimental | Medical research | Gene mutations | Health aspects | Analysis | Statistical analysis | Population studies | Group dynamics | Males | Patients | Epidemiology | Subgroups | Population (statistical) | Multiple endocrine neoplasia | Genetics | Diagnosis | Lesions | Females | Natural history | Tumors | Neuroendocrine tumors
Journal Article
Gastric Cancer, ISSN 1436-3291, 4/2015, Volume 18, Issue 2, pp. 346 - 353
The aim of this retrospective study was to evaluate the changes in clinical features and treatment outcomes of the patients with metastatic or recurrent... 
Treatment outcome | Prognosis | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Period | Surgical Oncology | Stomach neoplasm | 1ST-LINE TREATMENT | OPEN-LABEL | SALVAGE CHEMOTHERAPY | CAPECITABINE | SUPPORTIVE CARE | THERAPY | CISPLATIN | ONCOLOGY | RANDOMIZED PHASE-III | COMBINATION CHEMOTHERAPY | 3-WEEK COMBINATION | GASTROENTEROLOGY & HEPATOLOGY | Bone Neoplasms - mortality | Lung Neoplasms - drug therapy | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Neoplasm Recurrence, Local - drug therapy | Male | Stomach Neoplasms - pathology | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Peritoneal Neoplasms - secondary | Survival Rate | Lymphatic Metastasis | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Medical colleges | Chemotherapy | Relapse | Patient outcomes | Analysis | Metastasis | Bilirubin | Stomach cancer | Cancer | Diseases
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 109 - 115
Objectives The optimal adjuvant therapy for International Federation of Gynecology and Obstetrics (FIGO) stage I papillary serous (UPSC) or clear cell (CC)... 
Radiology | Hematology, Oncology and Palliative Medicine | SURGERY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | ADENOCARCINOMA | RANDOMIZED-TRIAL | ADJUVANT RADIATION-THERAPY | RADIOTHERAPY | CARCINOMA | FAILURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Cystadenocarcinoma, Papillary - secondary | Endometrial Neoplasms - radiotherapy | Abdominal Neoplasms - secondary | Follow-Up Studies | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Pelvic Neoplasms - mortality | Adenocarcinoma, Clear Cell - radiotherapy | Vaginal Neoplasms - secondary | Pelvic Neoplasms - secondary | Cystadenocarcinoma, Papillary - pathology | Aged, 80 and over | Cystadenocarcinoma, Papillary - mortality | Adult | Female | Adenocarcinoma, Clear Cell - surgery | Cystadenocarcinoma, Papillary - surgery | Cystadenocarcinoma, Papillary - radiotherapy | Brachytherapy - methods | Hysterectomy - methods | Survival Rate | Radiotherapy Dosage - standards | Vaginal Neoplasms - mortality | Analysis of Variance | Adenocarcinoma, Clear Cell - secondary | Abdominal Neoplasms - mortality | Radiotherapy, Adjuvant - methods | Endometrial Neoplasms - surgery | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Lymph Node Excision - methods | Care and treatment | Endometrial cancer | Radioisotope brachytherapy | Nuclear radiation | Surgery | Cancer | PATIENTS | WOMEN | HEALTH HAZARDS | NEOPLASMS | LYMPH NODES | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | BRACHYTHERAPY | DOSE RATES | GYNECOLOGY
Journal Article
Radiation Oncology, ISSN 1748-717X, 08/2018, Volume 13, Issue 1, pp. 143 - 11
Background: We sought to determine the role of abdominal reirradiation for patients presenting with recurrent or new primary gastrointestinal (GI)... 
External beam | Gastrointestinal malignancies | Reirradiation | Local control | Toxicity | Hyperfractionated | Abdominal | PANCREATIC-CANCER | THERAPY ONCOLOGY GROUP | PHASE-II | CURATIVE RESECTION | RANDOMIZED-TRIAL | RADIATION-THERAPY | LOCAL RECURRENCE | ONCOLOGY | GASTRIC-CANCER | RECURRENT RECTAL-CANCER | SURGICAL RESECTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Colonic Neoplasms - radiotherapy | Neoplasm Recurrence, Local - radiotherapy | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Radiation Dose Hypofractionation | Biliary Tract Neoplasms - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Biliary Tract Neoplasms - radiotherapy | Female | Pancreatic Neoplasms - mortality | Adenocarcinoma - radiotherapy | Colonic Neoplasms - mortality | Reproducibility of Results | Kaplan-Meier Estimate | Pancreatic Neoplasms - radiotherapy | Re-Irradiation - methods | Analysis of Variance | Gastrointestinal Neoplasms - radiotherapy | Liver Neoplasms - radiotherapy | Progression-Free Survival | Aged | Adenocarcinoma - mortality | Care and treatment | Usage | Research | Radiotherapy | Gastrointestinal cancer | Patient outcomes | Adenocarcinoma | Signs and symptoms | Hazard identification | Radiation | Nausea | Metastasis | Radiation therapy | Pelvis | Patients | Cancer therapies | Survival | Bleeding | Abdomen | Side effects | Biological effects | Statistical models | Pancreatic cancer | Colon | Pancreas | Tumors
Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2017, Volume 20, Issue 2, pp. 387 - 393
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 2/2016, Volume 23, Issue 2, pp. 626 - 632
Journal Article